BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25135354)

  • 1. Phosphorylation enhances recombinant HSP27 neuroprotection against focal cerebral ischemia in mice.
    Shimada Y; Tanaka R; Shimura H; Yamashiro K; Urabe T; Hattori N
    Neuroscience; 2014 Oct; 278():113-21. PubMed ID: 25135354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-derived physiological heat shock protein 27 complex protects brain after focal cerebral ischemia in mice.
    Teramoto S; Shimura H; Tanaka R; Shimada Y; Miyamoto N; Arai H; Urabe T; Hattori N
    PLoS One; 2013; 8(6):e66001. PubMed ID: 23785464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined metabolic and transcriptional profiling identifies pentose phosphate pathway activation by HSP27 phosphorylation during cerebral ischemia.
    Imahori T; Hosoda K; Nakai T; Yamamoto Y; Irino Y; Shinohara M; Sato N; Sasayama T; Tanaka K; Nagashima H; Kohta M; Kohmura E
    Neuroscience; 2017 May; 349():1-16. PubMed ID: 28257891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of HSP27 by protein kinase D is essential for mediating neuroprotection against ischemic neuronal injury.
    Stetler RA; Gao Y; Zhang L; Weng Z; Zhang F; Hu X; Wang S; Vosler P; Cao G; Sun D; Graham SH; Chen J
    J Neurosci; 2012 Feb; 32(8):2667-82. PubMed ID: 22357851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of compound FLZ in an ischemic model mediated by improving cerebral blood flow and enhancing Hsp27 expression.
    Ma B; Li M; Ma T; Liu GT; Zhang J
    Brain Res; 2016 Aug; 1644():288-95. PubMed ID: 24675028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis.
    Wang X; Wang H; Xu L; Rozanski DJ; Sugawara T; Chan PH; Trzaskos JM; Feuerstein GZ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):172-8. PubMed ID: 12490588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentose phosphate pathway activation via HSP27 phosphorylation by ATM kinase: A putative endogenous antioxidant defense mechanism during cerebral ischemia-reperfusion.
    Yamamoto Y; Hosoda K; Imahori T; Tanaka J; Matsuo K; Nakai T; Irino Y; Shinohara M; Sato N; Sasayama T; Tanaka K; Nagashima H; Kohta M; Kohmura E
    Brain Res; 2018 May; 1687():82-94. PubMed ID: 29510140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection of hypoxic postconditioning against global cerebral ischemia through influencing posttranslational regulations of heat shock protein 27 in adult rats.
    Zhan L; Liu L; Li K; Wu B; Liu D; Liang D; Wen H; Wang Y; Sun W; Liao W; Xu E
    Brain Pathol; 2017 Nov; 27(6):822-838. PubMed ID: 27936516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
    Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
    Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geranylgeranylacetone attenuates cerebral ischemia-reperfusion injury in rats through the augmentation of HSP 27 phosphorylation: a preliminary study.
    Matsuo K; Hosoda K; Tanaka J; Yamamoto Y; Imahori T; Nakai T; Irino Y; Shinohara M; Sasayama T; Kohmura E
    BMC Neurosci; 2021 Feb; 22(1):9. PubMed ID: 33557752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of heat shock protein 27 reduces cortical damage after cerebral ischemia.
    van der Weerd L; Tariq Akbar M; Aron Badin R; Valentim LM; Thomas DL; Wells DJ; Latchman DS; Gadian DG; Lythgoe MF; de Belleroche JS
    J Cereb Blood Flow Metab; 2010 Apr; 30(4):849-56. PubMed ID: 19997117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The loss of estrogen efficacy against cerebral ischemia in aged postmenopausal female mice.
    Cai M; Ma YL; Qin P; Li Y; Zhang LX; Nie H; Peng Z; Dong H; Dong HL; Hou WG; Xiong LZ
    Neurosci Lett; 2014 Jan; 558():115-9. PubMed ID: 24246902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells.
    Katayama Y; Inaba T; Nito C; Ueda M; Katsura K
    Brain Res; 2014 Nov; 1588():159-67. PubMed ID: 25264351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
    Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
    Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling.
    Stetler RA; Cao G; Gao Y; Zhang F; Wang S; Weng Z; Vosler P; Zhang L; Signore A; Graham SH; Chen J
    J Neurosci; 2008 Dec; 28(49):13038-55. PubMed ID: 19052195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
    Thiyagarajan M; Kaul CL; Sharma SS
    Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.